MS

Mittalal Surajmal

Director Director DIN 02318356
DIN 02318356 First appointment Jan 1991 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 1991
Shareholding value Locked Premium profile

About Mittalal Surajmal

Data last updated:

Mittalal Surajmal has 35 years in corporate governance. Formerly with 1 company, such as Axon Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02318356
Primary Designation Director
First Appointment 21 Jan 1991
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Axon Drugs Private Limited U24117TN1990PTC019380
Director21 Jan 19911990Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Axon Drugs Private Limited
Premium access

Shareholding and investment profile for Mittalal Surajmal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mittalal Surajmal

Mittalal Surajmal has 35 years in corporate governance. Formerly with 1 company, such as Axon Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Mittalal Surajmal is associated with 0 companies as a director.

Mittalal Surajmal has expertise in General Business.

Mittalal Surajmal has 35 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available